Group leader
The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.
Bioaction is an EU-funded project, in which IBEC is involved, that aims to revolutionize the approach to implant-associated infections. By harnessing hydrogels and smart nanomaterials, Bioaction will transform bacterial biofilms into bio-factories for tissue regeneration, offering a novel alternative to traditional antibiotic therapies. The project is driven by a multidisciplinary team of experts and strives to improve patient outcomes while addressing the global challenge of antimicrobial resistance.
IBEC researchers Elisabeth Engel and Gabriel Gomila have been awarded the “ICREA Acadèmia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). Engel and Gomila, who lead their … Read more
During the visit, the President of the Government of Catalonia, Pere Aragonès i Garcia, and the Minister of Health, Manel Balcells i Díaz, were able to learn first-hand about several … Read more
Lead researcher Eli Engel and IBEC researcher Bárbara Blanco are featured on RTVE for their recent research against breast cancer. Using 3D bioprinting they have created tumors from pig tissue. … Read more
IBEC researchers led by Elisabeth Engel are in the media for their new tool against breast cancer: 3D bioprinting of tumors using pig tissue. The study, led by group leader … Read more
Ref: PostDoc / Deadline: 31st July 2022
